Table 3.
GNRI model | MNA–SF model | |||
---|---|---|---|---|
Parameters | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex | ||||
Male | Ref. | Ref. | ||
Female | 0.883 (0.638–1.224) | 0.637 | 1.070 (0.771–1.486) | 0.684 |
Age | 1.004 (0.971–1.038) | 0.836 | 1.016 (0.982–1.051) | 0.366 |
Charlson Comorbidity Index | 0.807 (0.544–1.195) | 0.248 | 0.789 (0.529–1.176) | 0.244 |
Heng risk stratification | ||||
Low | Ref. | Ref. | ||
Intermediate | 2.601 (1.630–4.148) | <0.001 | 2.741 (1.724–4.359) | <0.001 |
High | 3.929 (2.155–7.163) | <0.001 | 5.696 (3.185–10.19) | <0.001 |
Nephrectomy | ||||
No | Ref. | Ref. | ||
Yes | 0.560 (0.228–1.378) | 0.207 | 0.492 (0.198–1.222) | 0.126 |
NLR | ||||
≤5 | Ref. | Ref. | ||
>5 | 1.541 (0.728–3.264) | 0.259 | 1.266 (0.208–2.638) | 0.528 |
Geographic location | ||||
Urban | Ref. | Ref. | ||
Rural | 1.506 (1.085–2.091) | 0.014 | 1.696 (1.226–2.346) | 0.001 |
Nutrition risk | ||||
Normal | Ref | Ref. | ||
Low | 1.502 (1.069–2.498) | 0.023 | 1.320 (0.886–1.967) | 0.172 |
High | 3.157 (2.273–5.353) | <0.001 | 2.784 (1.506–6.065) | 0.002 |
Incremental performance (using Heng model as benchmark) | ||||
△ C index | 0.041 | 0.016 | ||
IDI at 2 years (95%CI) | 0.066 (0.024–0.113) | P = 0.001 | 0.013 (-0.005-0.050) | P = 0.239 |
NRI at 2 years (95%CI) | 0.177 (0.057–0.363) | P = 0.013 | 0.123 (-0.134–0.245) | P = 0.286 |
△ Net benefit at threshold of 50% at 2 years | 1.2 per 100 patients | 0.9 per 100 patients | ||
△ Net benefit at threshold of 62%* at 2 years | 4.5 per 100 patients | 2.8 per 100 patients |
Abbreviations: GNRI, Geriatric Nutritional Risk Index; MNA–SF, Mini Nutritional Assessment–Short Form; HR, hazard ratio; NLR, neutrophil lymphocyte ratio; C index, Harrell's concordance index; IDI, integrated discrimination improvement index; NRI, net reclassification index
For the entire group, 2-year survival rate was 38%.